Mean age (yr) |
64.6 |
69.1 |
66.1 |
Male/female distribution by 159 lesions |
26/29 |
31/8 |
37/28 |
Presentation |
|
|
|
Mean days from first symptom to treatment |
69.3 |
48.5 |
61.0 |
Mean presenting mRS |
1.5 |
1.4 |
1.6 |
Mean stenosis before treatment of 159 primary lesions (%) |
83 |
77 |
78 |
Transient ischemic attack (n = 61) |
19 |
19 |
23 |
Minor stroke (change of 0–1 in mRS, n = 45) |
20 |
9 |
16 |
Major stroke (change of ≥2 in mRS, n = 52) |
15 |
11 |
26 |
Vessel and lesion characteristics for all 159 lesions |
|
|
|
Lesions per device |
55 |
39 |
65 |
<70% stenosis |
2 |
4 |
7 |
≥70% stenosis |
53 |
35 |
58 |
Perforators |
32 |
13 |
47 |
Nonperforators |
23 |
26 |
18 |
Smooth lesion |
31 |
27 |
41 |
Irregular lesion |
17 |
12 |
20 |
Concentric lesion |
20 |
16 |
41 |
Eccentric lesion |
28 |
23 |
20 |
Short lesion (<5 mm) |
19 |
18 |
22 |
Moderate lesion (5–10 mm) |
6 |
11 |
10 |
Long lesion (>10 mm) |
23 |
10 |
29 |
Vessel and lesion characteristics for all 209 interventions |
|
|
|
Interventions per device |
89 |
47 |
73 |
<70% stenosis |
9 |
5 |
8 |
≥70% stenosis |
79 |
43 |
65 |
Perforators |
51 |
14 |
54 |
Nonperforators |
38 |
33 |
19 |
Smooth lesion |
57 |
33 |
46 |
Irregular lesion |
20 |
15 |
22 |
Concentric lesion |
40 |
21 |
46 |
Eccentric lesion |
37 |
27 |
22 |
Short lesion (<5 mm) |
26 |
20 |
22 |
Moderate lesion (5–10 mm) |
9 |
11 |
10 |
Long lesion (>10 mm) |
42 |
17 |
36 |
Activating clotting time at deployment (s) |
212 |
212 |
217 |
Duration of procedure (min) |
163 |
149 |
154 |